We demonstrate using a panel of CRC cell lines the sensitivity to AZD1208 Pim inhibitors of cells with PAI1 expression, suggesting that PAI1 could be used as a prognosis marker to stratify rectal cancer patients and predict increased efficacy of this Pim kinase inhibitor in those with a bad prognosis. Here, PIM1 is linked to colorectal carcinoma.